HUMA · Humacyte, Inc. · Executive Compensation
$0.44
+0.02 (+5.40%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company will not have sufficient liquidity to fund its operations beyond one year from the issuance of these condensed consolidated financial statements if the Company is unable to generate sufficient cash flows from commercial sales on a timely basis and/or obtain additional capital. These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$120.95M
Shares
277.80M
Volume · Oct 23
2.61M
Avg daily vol (3M)
6.43M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Laura Niklason | President and Chief Executive Officer | $5,234,908 |
| Laura E. Niklason | President and Chief Executive Officer | $5,234,908 |
| Dale Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $2,131,658 |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $2,131,658 |
| Shamik J. Parikh | Chief Medical Officer | $2,096,556 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Laura Niklason | President and Chief Executive Officer | $905,436 |
| Laura E. Niklason | President and Chief Executive Officer | $905,436 |
| Dale Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $704,189 |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $704,189 |
| Heather Prichard | Chief Operating Officer | $653,205 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Laura Niklason | President and Chief Executive Officer | $2,625,702 |
| Laura E. Niklason | President and Chief Executive Officer | $2,625,702 |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $1,351,483 |
| Dale Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $1,351,483 |
| Heather Prichard | Chief Operating Officer | $1,271,283 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Laura Niklason | President and Chief Executive Officer | $1,749,088 |
| Laura E. Niklason | President and Chief Executive Officer | $1,749,088 |
| Shamik J. Parikh | Chief Medical Officer | $1,530,141 |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $982,969 |
| Dale Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | $982,969 |
| Heather Prichard | Chief Operating Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Laura E. Niklason | President and Chief Executive Officer | $10,803,096 |
| Laura Niklason | President and Chief Executive Officer | $10,803,096 |
| Jeffrey H. Lawson | Former Chief Surgical Officer | $907,000 |
| Heather Prichard | Chief Operating Officer | $576,436 |
| Rajiv Shukla | Former Chief Executive Officer of AHAC | $115,414 |
| Dale Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | — |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer and Treasurer | — |
| Shamik J. Parikh | Chief Medical Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jeffrey H. Lawson | Former Chief Surgical Officer | $713,901 |
| Heather Prichard | Chief Operating Officer | $483,706 |
| Laura E. Niklason | President and Chief Executive Officer | $201,283 |
| Laura Niklason | President and Chief Executive Officer | $201,283 |
| Rajiv Shukla | Former Chief Executive Officer of AHAC | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Paul Kuznik | Class II director | Appointed | 2026-09-28 |
| Scott Coward | Class I director | Appointed | 2026-09-28 |
| Laura E. Niklason | Class III Director | Appointed | 2024-06-13 |
| Susan Windham-Bannister | Class III Director | Appointed | 2024-06-13 |
| Keith Anthony Jones | Class III Director | Resigned | 2024-06-13 |
| Keith Anthony Jones | Class III Director | Appointed | 2024-06-13 |
| Emery N. Brown | Class III Director | Appointed | 2024-06-13 |
| Michael T. Constantino | Class III Director | Appointed | 2024-06-13 |
| John P. Bamforth | Class III Director | Resigned | 2024-06-13 |
| John P. Bamforth | Class III Director | Appointed | 2024-06-13 |
| Yang (Cindy) Cao | Chief Regulatory Officer | Appointed | 2022-09-20 |
| C. Bruce Green | Class I director | Appointed | 2022-09-20 |
Leadership
- Laura E. Niklason CEO, Board Member
- Laura Niklason CEO, Board Member
- Dale A. Sander CFO
- Dale Sander CFO
- Heather Prichard COO
- Brady W. Dougan Board Member
- C. Bruce Green Board Member
- Diane Seimetz Board Member
- Emery N. Brown Board Member
- John P. Bamforth Board Member
- Kathleen Sebelius Board Member
- Keith Anthony Jones Board Member
- Max Wallace Board Member
- Michael T. Constantino Board Member
- Paul Kuznik Board Member
- Scott Coward Board Member
- Susan Windham-Bannister Board Member
- Todd M. Pope Board Member
Key facts
CIK
1818382
CUSIP
44486Q103
13F (30d)
24 filings
24 filers
Visit website
Investor relations